MSB 3.19% 97.0¢ mesoblast limited

Ann: Update on BLA for Graft Versus Host Disease, page-248

  1. 137 Posts.
    lightbulb Created with Sketch. 26
    I just got in this morning. I'm surprised by the huge panic selling. I'm a life scientist in academic research myself and I can see where FDA is coming from. FDA as a huge agency and a world leader, it makes sense for them to be extra cautious over the approval of a never before new drug. In another words, FDA is putting the whole organisation and reputation on the line if they do approve. Hence, I am not surprise they want to be cautious. GLTAH.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.